Skip to main content

The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about The SQUID Trial for the Embolization of the Middle Meningeal Artery for Treatment of Chronic Subdural Hematoma (STEM)

Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Roll Over StudY for Patients Who Have Completed a Previous Oncology Study With Olaparib

Use of Remote Monitoring for COVID-19 Patient

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Use of Remote Monitoring for COVID-19 Patient

Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of Remdesivir (GS-5734™) in Participants From Birth to < 18 Years of Age With Coronavirus Disease 2019 (COVID-19)

A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about A Study to Evaluate the Efficacy and Safety of Dupilumab in Participants With Allergic Bronchopulmonary Aspergillosis (ABPA) (LIBERTY ABPA AIRED)

Centrally Acting ACE Inhibition in SLE

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Centrally Acting ACE Inhibition in SLE

FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about FLT3 Ligand, CD40 Agonist Antibody, and Stereotactic Radiotherapy

Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

InterStim Micro Post Market Clinical Follow-up Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about InterStim Micro Post Market Clinical Follow-up Study

Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Submitted by Anonymous (not verified) on Mon, 05/23/2022 - 14:03
  • Read more about Tumor-Agnostic Precision Immuno-Oncology and Somatic Targeting Rational for You (TAPISTRY) Platform Study

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 202
  • Page 203
  • Page 204
  • Page 205
  • Page 206
  • Page 207
  • Page 208
  • Page 209
  • Page 210
  • …
  • Next page Next
  • Last page Last
Subscribe to